BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dardiotis E, Tsouris Z, Aslanidou P, Aloizou A, Sokratous M, Provatas A, Siokas V, Deretzi G, Hadjigeorgiou GM. Body mass index in patients with Multiple Sclerosis: a meta-analysis. Neurological Research 2019;41:836-46. [DOI: 10.1080/01616412.2019.1622873] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Høglund RAA, Meyer HE, Stigum H, Torkildsen Ø, Grytten N, Holmøy T, Nakken O. Association of Body Mass Index in Adolescence and Young Adulthood and Long-term Risk of Multiple Sclerosis: A Population-Based Study. Neurology 2021;97:e2253-61. [PMID: 34697245 DOI: 10.1212/WNL.0000000000012957] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Silverstein SM, Demmin DL, Schallek JB, Fradkin SI. Measures of Retinal Structure and Function as Biomarkers in Neurology and Psychiatry. Biomarkers in Neuropsychiatry 2020;2:100018. [DOI: 10.1016/j.bionps.2020.100018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 4.5] [Reference Citation Analysis]
3 Andravizou A, Dardiotis E, Artemiadis A, Sokratous M, Siokas V, Tsouris Z, Aloizou AM, Nikolaidis I, Bakirtzis C, Tsivgoulis G, Deretzi G, Grigoriadis N, Bogdanos DP, Hadjigeorgiou GM. Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options. Auto Immun Highlights 2019;10:7. [PMID: 32257063 DOI: 10.1186/s13317-019-0117-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
4 Andravizou A, Artemiadis A, Bakirtzis C, Siokas V, Aloizou A, Peristeri E, Kapsalaki E, Tsimourtou V, Hadjigeorgiou GM, Dardiotis E. Brain volume dynamics in multiple sclerosis. A case-control study. Neurological Research 2019;41:936-42. [DOI: 10.1080/01616412.2019.1637041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lima M, Aloizou AM, Siokas V, Bakirtzis C, Liampas I, Tsouris Z, Bogdanos DP, Baloyannis SJ, Dardiotis E. Coronaviruses and their relationship with multiple sclerosis: is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia? Rev Neurosci 2022. [PMID: 35258237 DOI: 10.1515/revneuro-2021-0148] [Reference Citation Analysis]
6 Siokas V, Katsiardanis K, Aloizou AM, Bakirtzis C, Liampas I, Koutlas E, Rudolf J, Ntinoulis K, Kountouras J, Dardiotis E, Deretzi G. Impact of Body Mass Index on the Age of Relapsing-Remitting Multiple Sclerosis Onset: A Retrospective Study. Neurol Int 2021;13:517-26. [PMID: 34698268 DOI: 10.3390/neurolint13040051] [Reference Citation Analysis]
7 Alsomali N, Alsharif R, Albalawi B, Alharthi R, Junaidallah W, Alshammari S, Alhawiti F, Alenezi A, Alarieh R, Alsaeed W, Altowaijri G. Lack of association between B 12 and Body Mass Index among Saudi multiple sclerosis patients. Metabolism Open 2022;14:100181. [DOI: 10.1016/j.metop.2022.100181] [Reference Citation Analysis]
8 Tadić D, Đajić V, Grgić S, Miljković S. Association of body mass index with progression and prediction of multiple sclerosis. Scripta Medica 2020;51:34-40. [DOI: 10.5937/scriptamed51-24916] [Reference Citation Analysis]
9 Wesnes K, Myhr KM, Riise T, Kvistad SS, Torkildsen Ø, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Bjørnevik K. Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis. Mult Scler Relat Disord 2021;50:102801. [PMID: 33636616 DOI: 10.1016/j.msard.2021.102801] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Vandebergh M, Degryse N, Dubois B, Goris A. Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies. J Neurol 2022. [PMID: 35366084 DOI: 10.1007/s00415-022-11072-4] [Reference Citation Analysis]